MobiHealth News July 2, 2020
Despite the uncertainty of COVID-19, funding deals during the last three months were generally on par with those of Q1 2020 and Q2 2019.
As the broader economy ping pongs between state lockdowns, unemployment reports and escalating public markets, COVID-19 still down’t appear to have torpedoed investors’ interests in digital health.
During the second quarter of 2020, MobiHealthNews tracked 89 funding deals totaling $2.44 billion – a slight increase in volume but decline in value when compared to both Q2 2019 (81 deals, $2.45 billion) and Q1 2020 (82 deals, $2.9 billion). That broader spread of funds isn’t to say that there weren’t some heavy-hitting deals this quarter, as startups focused on insurtech, telehealth, artificial intelligence drug discovery, and tech-enabled...